News & Events
Published On: 8/24/2022
Durham-Based Target RWE Grows Data Abstraction, Curation Capabilities with Latest Acquisition
DURHAM, N.C., Aug. 24, 2022 /PRNewswire/ -- Real-world evidence leader Target RWE announced its latest acquisition of the curation team (legacy Real World Data team) from Ciox Health which will expand the company's real world data (RWD) solutions and capabilities. Effective today, this division will become part of Target RWE.
Over the past two years, Target RWE has been strategically investing in its real-world evidence (RWE) solutions, most notably with the purchase of analytics company NoviSci, Inc. in 2021. This will be the second acquisition completed by the company. The acquisition complements Target RWE's data abstraction and curation capabilities, especially on the retrieval and linking of real world datasets, which will help position the company as a market leader in the RWE field.
"Today's agreement not only propels Target RWE's data abstraction and curation capabilities, but it also signifies our dedication to generate the best real world data and evidence possible," said Derek Evans, CEO of Target RWE. "We are excited to work with the great team coming over from Ciox, who will add further efficiencies in clinical data abstraction and curation to our organization. We look forward to bringing our expertise to exciting projects and new customers as a result of this new partnership."
The acquisition will add roughly 35 full-time and part-time employees to Target RWE, increasing the company's overall headcount to approximately 150 nationwide. The company recently announced the launch of its new brand and Syndicated Science™ solution that will be unveiled at the International Conference on Pharmacoepidemiology (ICPE) 2022 in Copenhagen.
About Target RWE
As the industry's best-in-class, complete real world evidence (RWE) solution, Target RWE is a distinctly collaborative enterprise that unifies real world data (RWD) sets and advanced RWE analytics in an integrated community, shifting the paradigm in healthcare for how decisions are made to improve lives.
Target RWE sources unique, connected data sets across multiple therapeutic areas representing granular data from diverse patients in academic and community settings. Our rigorous, interactive, and advanced RWE analytics extract deep insights from RWD to answer important questions in healthcare. Target RWE brings together the brightest minds in healthcare through an unmatched community of key opinion leaders, patients, and healthcare stakeholders in a collaborative and dynamic model. www.targetrwe.com
984.234.0268 ext 205
08/25/2022New Approaches for Developing Real-World Evidence Presented by Target RWE at the 2022 International Conference on Pharmacoepidemiology (ICPE)
08/24/2022Durham-Based Target RWE Grows Data Abstraction, Curation Capabilities with Latest Acquisition
08/23/2022Target RWE New Brand, Research, and Advanced Real World Evidence Analytics Showcased at International Conference on Pharmacoepidemiology (ICPE) 2022
07/20/2022Real-World Data Finds High Prevalence of Pruritus (Itching) and Fatigue, Low Levels of Treatment in Primary Biliary Cholangitis Population
06/24/2022Nonalcoholic Fatty Liver Disease (NAFLD) Research from Target RWE's Real-World Study Presented at International Liver Congress 2022